Max Healthcare Members Approve ESOP Scheme and MOA Alteration
Max Healthcare Institute Ltd announced that its members, through postal ballot and remote e-voting, have approved the 'Max Healthcare Institute Limited - Performance Linked Restricted Stock Unit Scheme 2026'. This scheme allows for the grant of up to 73,50,000 equity shares (approximately 0.76% of paid-up capital) with an exercise price equal to the face value of ₹10 per share. The exercise period is three years from the vesting date. Additionally, the members approved the alteration of the Main Objects Clause of the Memorandum of Association to include establishing medical colleges and dealing in pharmaceuticals. The disclosure also notes that no options have been granted or vested yet, making certain SEBI-related details not applicable at this time.
Key Highlights
- Members approved the Performance Linked Restricted Stock Unit Scheme 2026.
- Up to 73.5 lakh shares can be issued under the ESOP scheme.
- Exercise price set at ₹10 per share (face value).
- MOA alteration approved to expand into medical education and pharmaceuticals.
- No options granted or vested as of the disclosure date.
Price Impact
More from MAXHEALTH